Effect of MKC-733, a 5-HT3 receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study.
Background: MKC-733, a 5-HT3 receptor partial agonist, is a novel enteroprokinetic compound. Objective: The aim of this study was to explore the effects of MKC-733 on bowel motility and symptoms in a small group of subjects with constipation. Tolerability was also examined. Methods: The study was co...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 30; no. 6; pp. 611 - 623 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | clinical trial research Journal Article |
| Publicado: |
Wiley-Blackwell
Dec2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |